|
Visipaque 270Drug - Visipaque 270 The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Iodixanol
Strength -
55%
Applicant -
GE HEALTHCARE
New Drug Application (NDA) Number -
020351
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 22, 1996
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Ge Healthcare
Visipaque 270
Travert 10% In Plastic Container 10gm/100ml Injectable; Injection
Iobenguane Sulfate I 131 2.3mci/ml Injectable; Injection Cholebrine 750mg Tablet; Oral Renovue-65 65% Injectable; Injection Renovue-dip 24% Injectable; Injection Cholografin Meglumine 10.3% Injectable; Injection Cholografin Meglumine 52% Injectable; Injection Cholografin Sodium 20% Injectable; Injection Visipaque 270 55% Injectable; Injection Inulin And Sodium Chloride 100mg/ml Injectable; Injection NewDrugInformation |